Multimorbidity during pregnancy: clustering, racial disparity in pregnancy outcome and impact of multiple medications on infants

Eligibility: UK/International (including EU) graduates with the required entry requirements

Funding details: Bursary plus tuition fees (UK/International (including EU at international rates from Sept 23)

Duration: Full-Time – between three and three and a half years fixed term

Application deadline: 27 May 2023

Interview date: Will be confirmed to shortlisted candidates

Start date: September 2023

For further details contact Dr Abiodun Adanikin


Introduction

Coventry University (CU) is inviting applications from suitably qualified graduates for a fully funded PhD studentship in maternal and perinatal epidemiology to explore clustering of multimorbidity in women of childbearing age, associated racial disparity in pregnancy outcomes, and the impact of polypharmacy on infants of multimorbid women. The successful candidate will be hosted within the Centre for Healthcare Research from September 2023. The Centre for Healthcare Research is home to a vibrant research culture, where research is both transdisciplinary and multidisciplinary. Through the combination of academic and clinical expertise, and excellence in research and development, the centre supports skilled, compassionate, effective health care and best patient outcomes.

Project details

Multimorbidity is the occurrence of two or more long-term health conditions. It is a phenomenon commoner with aging. However, growing evidence suggests that younger populations are affected, and that about one in five women may enter pregnancy with multimorbidity. Although it is reasonably studied in some disciplines, not much is known about how long-term health conditions accumulate in women of childbearing age, the impacts on pregnancy and infant health, and associated racial disparities in outcomes.

This project aims to explore the trend and clustering of multimorbidity in women of childbearing age, investigate racial disparity in outcomes among multimorbidity pregnant women, and examine the impact of multiple medication use by multimorbid pregnant women on infant health.

Funding

Tuition fees, bursary, and additional allowances.

Benefits

The successful candidate will receive comprehensive research training including technical, personal and professional skills.

All researchers at Coventry University (from PhD to Professor) are part of the Doctoral College and Centre for Research Capability and Development, which provides support with high-quality training and career development activities. 

Candidate specification

  • A bachelor’s (honours) degree in a relevant discipline/subject area with a minimum classification of 2:1 and a minimum mark of 60% in the project element (or equivalent), or an equivalent award from an overseas institution.
    PLUS 
  • the potential to engage in innovative research and to complete the PhD within 3.5 years
  • An adequate proficiency in English must be demonstrated by applicants whose first language is not English. The general requirement is a minimum overall IELTS Academic score of 7.0 with a minimum of 6.5 in each of the four sections, or the TOEFL iBT test with a minimum overall score of 95 with a minimum of 21 in each of the four sections.

 For further details please visit: 

https://www.coventry.ac.uk/research/research-opportunities/research-students/making-an-application/research-entry-criteria/

Additional requirements

Evidence of prior research activity in women’s health, handling of routinely collected healthcare data, and use of statistical packages, such as Stata/R will be added advantage.


How to apply

To find out more about the project please contact Dr Abiodun Adanikin

All applications require full supporting documentation, and a covering letter, and an up-to 2000-word supporting statement is required showing how the applicant’s expertise and interests are relevant to the project.

Apply to Coventry University
 Queen’s Award for Enterprise Logo
University of the year shortlisted
QS Five Star Rating 2020